Table 2 Univariate and multivariate logistic regression of risk factors for synchronous bone metastasis.

From: Machine learning for synchronous bone metastasis risk prediction in high grade lung neuroendocrine carcinoma

Variable

Univariate

Multivariate

OR (95% CI)

P value

OR (95% CI)

P value

Age

0.99 (0.98–0.99)

 < 0.001

0.99 (0.98–0.99)

 < 0.001

Race

 White

Reference

Reference

 Black

0.77 (0.67–0.87)

 < 0.001

0.83 (0.72–0.95)

0.007

 Others

0.69 (0.57–0.83)

 < 0.001

0.73 (0.59–0.88)

0.002

Sex

 Male

Reference

Reference

 Female

0.73 (0.68–0.79)

 < 0.001

0.79 (0.73–0.85)

 < 0.001

Primary site

 Main bronchus

Reference

Reference

 Upper lobe of lung

0.90 (0.80–1.00)

0.059

0.97 (0.86–1.09)

0.587

 Middle lobe of lung

0.79 (0.63–0.97)

0.026

0.88 (0.70–1.11)

0.288

 Lower lobe of lung

0.97 (0.85–1.10)

0.602

1.02 (0.89–1.18)

0.686

 Overlapping lesion of lung

1.06 (0.78–1.42)

0.725

0.97 (0.70–1.33)

0.848

 Lung, NOS

1.06 (0.92–1.22)

0.395

1.03 (0.88–1.20)

0.751

Laterality

 Left

Reference

Reference

 Right

0.93 (0.87–1.00)

0.051

0.94 (0.87–1.01)

0.103

 Bilateral, single primary

1.66 (1.17–2.31)

0.003

0.79 (0.54–1.14)

0.217

 Paired site

1.46 (1.10–1.91)

0.007

1.07 (0.78–1.45)

0.669

 Others

0.61 (0.30–1.11)

0.128

0.53 (0.26–1.01)

0.069

Histology type

 LCNEC

Reference

Reference

 SCLC

1.50 (1.27–1.78)

 < 0.001

1.17 (0.98–1.40)

0.083

T stage

 T1

Reference

Reference

 T2

1.52 (1.33–1.74)

 < 0.001

1.29 (1.12–1.49)

 < 0.001

 T3

1.76 (1.53–2.02)

 < 0.001

1.34 (1.16–1.56)

 < 0.001

 T4

1.83 (1.62–2.08)

 < 0.001

1.33 (1.16–1.53)

 < 0.001

N stage

 N0

Reference

Reference

 N1

1.43 (1.20–1.72)

 < 0.001

1.24 (1.03–1.50)

0.022

 N2

2.03 (1.80–2.29)

 < 0.001

1.60 (1.41–1.82)

 < 0.001

 N3

2.90 (2.55–3.30)

 < 0.001

2.27 (1.98–2.60)

 < 0.001

Marital status

 Married

Reference

Reference

 Others

0.81 (0.76–0.87)

 < 0.001

0.87 (0.80–0.93)

 < 0.001

Brain metastasis

 No

Reference

Reference

 Yes

1.47 (1.34–1.60)

 < 0.001

1.39 (1.27–1.53)

 < 0.001

Liver metastasis

 No

Reference

Reference

 Yes

4.25 (3.95–4.58)

 < 0.001

3.87 (3.58–4.18)

 < 0.001

Lung metastasis

 No

Reference

Reference

 Yes

2.03 (1.85–2.22)

 < 0.001

1.48 (1.33–1.63)

 < 0.001

  1. OR odds ratio, CI confidence interval, NOS not otherwise specified, SCLC small cell lung cancer, LCNEC large cell neuroendocrine carcinoma.